The University of Queensland

The impact of Cisplatin-based chemotherapy on everyday attention

Troy, L., Littmann-Power, S. C., Kelly, B. J., Thomson, D. and Wyld, D. (1999). The impact of Cisplatin-based chemotherapy on everyday attention. Brain Impairment and Rehabilitation: A National Perspective. (pp. 140-142) Brisbane: Aust. Academic Press.

Breast cancer

Wyld, D. (1998). Breast cancer. Key Topics in Oncology. (pp. 30-36) edited by G D Hall, P M Patel and A S Protheroe. Oxford, United Kingdom: Bios Scientific Publication.

Exploring Unmet Needs in Prostate Cancer Care: A Cross-sectional Descriptive Study

Roberts, Natasha A., Esler, Rachel, Pearce, Adam, Wyld, David, Smith, Michael, Woollett, Kaylene, Mazariego, Carolyn and Roberts, Matthew J. (2024). Exploring Unmet Needs in Prostate Cancer Care: A Cross-sectional Descriptive Study. European Urology Open Science, 62, 36-42. doi: 10.1016/j.euros.2024.01.018

The unmet needs of pancreatic cancer carers are associated with anxiety and depression in patients and carers

Huynh, Thi N. T., Hartel, Gunter, Janda, Monika, Wyld, David, Merrett, Neil, Gooden, Helen, Neale, Rachel E. and Beesley, Vanessa L. (2023). The unmet needs of pancreatic cancer carers are associated with anxiety and depression in patients and carers. Cancers, 15 (22) 5307, 1-12. doi: 10.3390/cancers15225307

Factors that influence clinical trial participation for oncology patients in Australia: A scoping review

You, Kyung Ha, Lwin, Zarnie, Ahern, Elizabeth Stephanie, Roberts, Natasha Anne and Wyld, David (2023). Factors that influence clinical trial participation for oncology patients in Australia: A scoping review. JCO Oncology Practice, 19 (11_suppl), 111-111. doi: 10.1200/op.2023.19.11_suppl.111

The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosis

Guccione, Lisa, Gough, Karla, Drosdowsky, Allison, Price, Timothy, Pavlakis, Nick, Wyld, David, Ransom, David, Michael, Michael and Schofield, Penelope (2023). The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosis. Supportive Care in Cancer, 31 (10) 577, 1-11. doi: 10.1007/s00520-023-08034-5

Exploring equity in cancer treatment, survivorship, and service utilisation for culturally and linguistically diverse migrant populations living in Queensland, Australia: a retrospective cohort study

Scanlon, Brighid, Durham, Jo, Wyld, David, Roberts, Natasha and Toloo, Ghasem Sam (2023). Exploring equity in cancer treatment, survivorship, and service utilisation for culturally and linguistically diverse migrant populations living in Queensland, Australia: a retrospective cohort study. International Journal for Equity in Health, 22 (1) 175, 1-10. doi: 10.1186/s12939-023-01957-9

Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI

Arnfield, Evyn G., Tam, Laura, Pattison, David A., Younger, John, Chikatamarla, Venkata Avinash, Wyld, David, Burge, Matthew, McCormack, Louise, Ladwa, Rahul and Ramsay, Stuart (2023). Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI. Journal of Nuclear Cardiology, 30 (6), 1-16. doi: 10.1007/s12350-023-03345-w

Investigating the dietary knowledge, attitudes, and beliefs of Australian patients with cancer

Lee, Shu Fen, Brown, Teresa, Wyld, David, Edwards, Anna and Eastgate, Melissa (2023). Investigating the dietary knowledge, attitudes, and beliefs of Australian patients with cancer. Journal of Human Nutrition and Dietetics, 36 (3), 612-621. doi: 10.1111/jhn.13091

Rethinking cancer prevention for migrant populations in Queensland, Australia: A retrospective cohort study comparing culturally and linguistically diverse and Australian born cancer patients

Scanlon, Brighid, Wyld, David, Roberts, Natasha, Durham, Jo and Toloo, Ghasem (Sam) (2023). Rethinking cancer prevention for migrant populations in Queensland, Australia: A retrospective cohort study comparing culturally and linguistically diverse and Australian born cancer patients. Global Public Health, 18 (1) 2202213, 1-13. doi: 10.1080/17441692.2023.2202213

Australasian consensus statement on the identification, prevention and management of hormonal crises in patients with neuroendocrine neoplasms (NENs) undergoing peptide receptor radionuclide therapy (PRRT)

Li, Minmin, Chan, David L., Tapia Rico, Gonzalo, Cehic, Gabrielle, Lawrence, Ben, Wyld, David, Pattison, David A., Kong, Grace, Hicks, Rodney, Michael, Michael, Kiberu, Andrew Ddembe, Lim, Jennifer, Clifton-Bligh, Roderick, Tsang, Venessa, Roach, Paul J., Leyden, John, Diakos, Connie I., Price, Timothy J. and Pavlakis, Nick (2023). Australasian consensus statement on the identification, prevention and management of hormonal crises in patients with neuroendocrine neoplasms (NENs) undergoing peptide receptor radionuclide therapy (PRRT). Neuroendocrinology, 113 (3), 281-288. doi: 10.1159/000526848

Essential elements of optimal dietary and exercise referral practices for cancer survivors: expert consensus for medical and nursing health professionals

Joseph, Ria, Hart, Nicolas H., Bradford, Natalie, Wallen, Matthew P., Han, Chad Y., Pinkham, Elizabeth P., Hanley, Brigid, Lock, Gemma, Wyld, David, Wishart, Laurelie, Koczwara, Bogda, Chan, Alexandre, Agbejule, Oluwaseyifunmi Andi, Crichton, Megan, Teleni, Laisa, Holland, Justin J., Edmiston, Kelli, Naumann, Leonie, Brown, Teresa and Chan, Raymond J. (2023). Essential elements of optimal dietary and exercise referral practices for cancer survivors: expert consensus for medical and nursing health professionals. Supportive Care in Cancer, 31 (1) 46, 1-14. doi: 10.1007/s00520-022-07509-1

COVID-19 vaccine hesitancy, acceptance and informational needs in an Australian cancer population: a cross-sectional survey

Scanlon, Brighid, Wyld, David, Firman, Paul, Nakagaki, Midori, Durham, Jo, Kennedy, Glen, Moran, Paul, Smith, Michael and Gavin, Nicole (2022). COVID-19 vaccine hesitancy, acceptance and informational needs in an Australian cancer population: a cross-sectional survey. Australian Health Review, 47 (1), 110-118. doi: 10.1071/ah22142

Factors that influence clinical trial participation by patients with cancer in Australia: a scoping review protocol

You, Kyung Ha, Lwin, Zarnie, Ahern, Elizabeth, Wyld, David and Roberts, Natasha (2022). Factors that influence clinical trial participation by patients with cancer in Australia: a scoping review protocol. BMJ open, 12 (4) e057675, e057675. doi: 10.1136/bmjopen-2021-057675

Scoping to analyze oncology trial participation in Australia

You, Kyung Ha, Ahern, Elizabeth, Wyld, David, Lwin, Zarnie and Roberts, Natasha (2022). Scoping to analyze oncology trial participation in Australia. Seminars in Oncology, 49 (2), 178-181. doi: 10.1053/j.seminoncol.2022.04.003

The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosis

Guccione, Lisa, Gough, Karla, Drosdowsky, Allison, Price, Timothy, Pavlakis, Nick, Wyld, David, Ransom, David, Michael, Michael and Schofield, Penelope (2022). The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosis. Patient Education and Counseling, 105 (1), 212-220. doi: 10.1016/j.pec.2021.05.006

Equity across the cancer care continuum for culturally and linguistically diverse migrants living in Australia: a scoping review

Scanlon, Brighid, Brough, Mark, Wyld, David and Durham, Jo (2021). Equity across the cancer care continuum for culturally and linguistically diverse migrants living in Australia: a scoping review. Globalization and Health, 17 (1) 87, 87. doi: 10.1186/s12992-021-00737-w

The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trial

Molassiotis, Alex, Brown, Teresa, Cheng, Hui Lin, Byrnes, Angela, Chan, Raymond Javan, Wyld, David, Eastgate, Melissa, Yates, Patsy, Marshall, Andrea P, Fichera, Rebecca, Isenring, Liz, To, Ki Fung, Ko, Po Shan, Lam, Wang, Lam, Yuk Fong, Au, Lai Fan and Lo, Raymond See-kit (2021). The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trial. Nutrition Journal, 20 (1) 2, 2. doi: 10.1186/s12937-020-00657-2

Our experience of nursing/allied health practitioner led geriatric screening and assessment of older patients with cancer – a highly accessible model of care

Thaker, Darshit Arunbhai, McGuire, Peter, Bryant, Geoffrey, Wyld, David, Leach, Justine, Wheatley, Hermione, Snape-Jenkinson, Stella, Kelly, Bernadette, Bourke, Anne and Kennedy, Glen (2021). Our experience of nursing/allied health practitioner led geriatric screening and assessment of older patients with cancer – a highly accessible model of care. Journal of Geriatric Oncology, 12 (8), 1186-1192. doi: 10.1016/j.jgo.2021.05.003

Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours

Elston, Marianne S., Love, Amanda, Kevat, Dev, Carroll, Richard, Siow, Zhen Rong, Pattison, Sharon, Boyle, Veronica, Segelov, Eva, Strickland, Andrew H., Wyld, David, Gauci, Richard, Kennedy, Kim and Ransom, David (2021). Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours. Cancer Medicine, 10 (23), 8405-8411. doi: 10.1002/cam4.4345

Preclinical molecular PET-CT imaging targeting CDCP1 in colorectal cancer

Cuda, Tahleesa J., He, Yaowu, Kryza, Thomas, Khan, Tashbib, Tse, Brian W., Sokolowski, Kamil A., Liu, Cheng, Lyons, Nicholas, Gough, Madeline, Snell, Cameron E., Wyld, David K., Rose, Stephen, Riddell, Andrew D., Stevenson, Andrew R. L., Thomas, Paul A., Clark, David A., Puttick, Simon and Hooper, John D. (2021). Preclinical molecular PET-CT imaging targeting CDCP1 in colorectal cancer. Contrast Media and Molecular Imaging, 2021 3153278, 3153278. doi: 10.1155/2021/3153278

Prospective cohort study of an Australian cancer care services-led model of emergent care

Button, Elise, Gavin, Nicole C., Bates, Tracey, Ahmed, Deka, Nasato, Gillian, Wyld, David, Kennedy, Glen, Fennelly, Eileen, Smith, Michael, Northfield, Sarah and Yates, Patsy (2021). Prospective cohort study of an Australian cancer care services-led model of emergent care. Australian Health Review, 45 (5), 613-621. doi: 10.1071/AH20346

Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia

Gasper, Harry, Ahern, Elizabeth, Roberts, Natasha, Chan, Bryan, Hughes, Brett, Kennedy, Glen, Wyld, David, Eastgate, Melissa and Lwin, Zarnie (2021). Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia. BMJ Open, 11 (5) e044655, e044655. doi: 10.1136/bmjopen-2020-044655

Resilience and ongoing quality care for cancer clinical trials during COVID-19: experience from a tertiary hospital in Australia

Ives, Amy, Pusztai, Tricia, Keller, Jacqui, Ahern, Elizabeth, Chan, Bryan, Gasper, Harry, Wyld, David, Kennedy, Glen, Dickie, Graeme, Lwin, Zarnie and Roberts, Natasha A. (2021). Resilience and ongoing quality care for cancer clinical trials during COVID-19: experience from a tertiary hospital in Australia. Asia-Pacific Journal of Clinical Oncology, 18 (2), e141-e147. doi: 10.1111/ajco.13570

Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): the NETPET score as a prognostic biomarker

Chan, David L., Ulaner, Gary A., Pattison, David A., Wyld, David, Ladwa, Rahul, Kirchner, Julian, Li, Bob T, Lai, W Victoria, Pavlakis, Nick, Roach, Paul J and Bailey, Dale L (2021). Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): the NETPET score as a prognostic biomarker. Journal of Nuclear Medicine, 62 (9), 1278-1284. doi: 10.2967/jnumed.120.257659

Hemoglobin, body mass index, and age as risk factors for Paclitaxel- and Oxaliplatin-induced peripheral neuropathy

Mizrahi, David, Park, Susanna B., Li, Tiffany, Timmins, Hannah C., Trinh, Terry, Au, Kimberley, Battaglini, Eva, Wyld, David, Henderson, Robert D., Grimison, Peter, Ke, Helen, Geelan-Small, Peter, Marker, Julie, Wall, Brian and Goldstein, David (2021). Hemoglobin, body mass index, and age as risk factors for Paclitaxel- and Oxaliplatin-induced peripheral neuropathy. JAMA Network Open, 4 (2) e2036695, 1-14. doi: 10.1001/jamanetworkopen.2020.36695

Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015

Wyld, David, Moore, Julie, Tran, Nancy and Youl, Philippa (2021). Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015. Asia-Pacific Journal of Clinical Oncology, 17 (4), 350-358. doi: 10.1111/ajco.13503

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Kang, Eun Young, Cheasley, Dane, LePage, Cecile, Wakefield, Matthew J., da Cunha Torres, Michelle, Rowley, Simone, Salazar, Carolina, Xing, Zhongyue, Allan, Prue, Bowtell, David D. L., Mes-Masson, Anne-Marie, Provencher, Diane M., Rahimi, Kurosh, Kelemen, Linda E., Fasching, Peter A., Doherty, Jennifer A., Goodman, Marc T., Goode, Ellen L., Deen, Suha, Pharoah, Paul D. P., Brenton, James D., Sieh, Weiva, Mateoiu, Constantina, Sundfeldt, Karin, Cook, Linda S., Le, Nhu D., Anglesio, Michael S., Gilks, C. Blake, Huntsman, David G. ... Campbell, Ian G. (2021). Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses. Modern Pathology, 34 (1), 194-206. doi: 10.1038/s41379-020-0618-9

PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancer

Cuda, Tahleesa J., Riddell, Andrew D., Liu, Cheng, Whitehall, Vicki L., Borowsky, Jennifer, Wyld, David K., Burge, Matthew E., Ahern, Elizabeth, Griffin, Alison, Lyons, Nicholas J. R., Rose, Stephen E., Clark, David A., Stevenson, Andrew R. L., Hooper, John D., Puttick, Simon and Thomas, Paul A. (2020). PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancer. The Journal of Nuclear Medicine, 61 (11), 1576-1579. doi: 10.2967/jnumed.119.233312

Statistical Process Control assessed implementation fidelity of Patient Reported Outcome Measures (PROMs) in routine care

Roberts, Natasha A., Alexander, Kimberly, Wyld, David and Janda, Monika (2020). Statistical Process Control assessed implementation fidelity of Patient Reported Outcome Measures (PROMs) in routine care. Journal of Clinical Epidemiology, 127, 76-86. doi: 10.1016/j.jclinepi.2020.06.022

The utility of the implementation science framework “Integrated Promoting Action on Research Implementation in Health Services” (i-PARIHS) and the facilitator role for introducing patient-reported outcome measures (PROMs) in a medical oncology outpatient department

Roberts, Natasha A., Janda, Monika, Stover, Angela M., Alexander, Kimberly E., Wyld, David and Mudge, Alison (2020). The utility of the implementation science framework “Integrated Promoting Action on Research Implementation in Health Services” (i-PARIHS) and the facilitator role for introducing patient-reported outcome measures (PROMs) in a medical oncology outpatient department. Quality of Life Research, 30 (11), 3063-3071. doi: 10.1007/s11136-020-02669-1

Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: a population-based analysis

McGahan, William, Waterhouse, Mary A., O'Connell, Dianne L., Merrett, Neil D., Goldstein, David, Wyld, David, Burmeister, Elizabeth A., Jordan, Susan J. and Neale, Rachel E. (2020). Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: a population-based analysis. Pancreatology, 20 (7), 1458-1464. doi: 10.1016/j.pan.2020.07.405

Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort study

Kuchel, Anna, Ahern, Elizabeth, Collins, Stephanie, Whitehall, Vicki, Okano, Satomi, Pelecanos, Anita, Wyld, David, Eastgate, Melissa and Burge, Matthew (2020). Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort study. Asia-Pacific Journal of Clinical Oncology, 17 (1) ajco.13420, 84-93. doi: 10.1111/ajco.13420

Prognostic gene expression signature for high-grade serous ovarian cancer

Millstein, J., Budden, T., Goode, E.L., Anglesio, M.S., Talhouk, A., Intermaggio, M.P., Leong, H.S., Chen, S., Elatre, W., Gilks, B., Nazeran, T., Volchek, M., Bentley, R.C., Wang, C., Chiu, D.S., Kommoss, S., Leung, S.C.Y., Senz, J., Lum, A., Chow, V., Sudderuddin, H., Mackenzie, R., George, J., Fereday, S., Hendley, J., Traficante, N., Steed, H., Koziak, J.M., Köbel, M. ... AOCS Group (2020). Prognostic gene expression signature for high-grade serous ovarian cancer. Annals of Oncology, 31 (9), 1240-1250. doi: 10.1016/j.annonc.2020.05.019

Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours

Lim, Lisi Elizabeth, Chan, David L., Thomas, David, Du, Yang, Tincknell, Gary, Kuchel, Anna, Davis, Alexander, Bailey, Dale L., Pavlakis, Nick, Cehic, Gabrielle, Macdonald, William, Wyld, David and Segelov, Eva (2020). Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours. OncoTarget, 11 (27), 2636-2646. doi: 10.18632/oncotarget.27659

The (co)production of difference in the care of patients with cancer from migrant backgrounds

Broom, Alex, Parker, Rhiannon, Raymond, Stephanie, Kirby, Emma, Lewis, Sophie, Kokanović, Renata, Adams, Jonathan, de Souza, Paul, Woodland, Lisa, Wyld, David, Lwin, Zarnie and Koh, Eng-Siew (2020). The (co)production of difference in the care of patients with cancer from migrant backgrounds. Qualitative Health Research, 30 (11), 1049732320930699-1631. doi: 10.1177/1049732320930699

Supporting patients and carers affected by pancreatic cancer: a feasibility study of a counselling intervention

Beesley, Vanessa L., Turner, Jane M., Chan, Raymond J., Yates, Patsy, Gordon, Louisa G., Burge, Matthew, Eastgate, Melissa A., Staneva, Aleksandra A., Northfield, Sarah, Beebe, Hanna, Wyld, David K. and Neale, Rachel E. (2020). Supporting patients and carers affected by pancreatic cancer: a feasibility study of a counselling intervention. European Journal of Oncology Nursing, 46 101729, 101729. doi: 10.1016/j.ejon.2020.101729

The economic impact on Australian patients with neuroendocrine tumours

Gordon, Louisa G., Elliott, Thomas M., Wakelin, Kate, Leyden, Simone, Leyden, John, Michael, Michael, Pavlakis, Nick, Mumford, Jan, Segelov, Eva and Wyld, David K. (2020). The economic impact on Australian patients with neuroendocrine tumours. The Patient - Patient-Centered Outcomes Research, 13 (3), 363-373. doi: 10.1007/s40271-020-00412-z

The INTERNET STUDY: a phase II study of everolimus in patients with fluorodeoxyglucose (18F) positron-emission tomography positive intermediate grade pancreatic neuroendocrine tumors

Lung, Mei Sim, Hicks, Rodney J, Pavlakis, Nick, Link, Emma, Jefford, Michael, Thomson, Benjamin, Wyld, David K, Liauw, Winston, Akhurst, Timothy, Kuru, Narmatha and Michael, Michael (2020). The INTERNET STUDY: a phase II study of everolimus in patients with fluorodeoxyglucose (18F) positron-emission tomography positive intermediate grade pancreatic neuroendocrine tumors. Asia-Pacific Journal of Clinical Oncology, 16 (3) ajco.13307, 150-157. doi: 10.1111/ajco.13307

Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma

Kryza, Thomas, Khan, Tashbib, Puttick, Simon, Li, Chao, Sokolowski, Kamil A., Tse, Brian W.C., Cuda, Tahleesa, Lyons, Nicholas, Gough, Madeline, Yin, Julia, Parkin, Ashleigh, Deryugina, Elena I., Quigley, James P., Law, Ruby H.P., Whisstock, James C., Riddell, Andrew D., Barbour, Andrew P., Wyld, David K., Thomas, Paul A., Rose, Stephen, Snell, Cameron E., Pajic, Marina, He, Yaowu and Hooper, John D. (2020). Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma. Theranostics, 10 (9), 4116-4133. doi: 10.7150/thno.43589

Defining the supportive care needs and psychological morbidity of patients with functioning versus nonfunctioning neuroendocrine tumors: Protocol for a phase 1 trial of a nurse-led online and phone-based intervention

Guccione, Lisa, Gough, Karla, Drosdowsky, Allison, Fisher, Krista, Price, Timothy, Pavlakis, Nick, Khasraw, Mustafa, Wyld, David, Ransom, David, Kong, Grace, Rogers, Megan, Leyden, Simone, Leyden, John, Michael, Michael and Schofield, Penelope (2019). Defining the supportive care needs and psychological morbidity of patients with functioning versus nonfunctioning neuroendocrine tumors: Protocol for a phase 1 trial of a nurse-led online and phone-based intervention. JMIR Research Protocols, 8 (12) e14361, e14361. doi: 10.2196/14361

Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia

Wyld, David, Wan, Mark H., Moore, Julie, Dunn, Nathan and Youl, Philippa (2019). Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia. Cancer Epidemiology, 63 101598, 101598. doi: 10.1016/j.canep.2019.101598

Factors in randomized controlled trials reported to impact the implementation of patient-reported outcome measures into routine care: protocol for a systematic review

Roberts, Natasha Anne, Alexander, Kimberly, Wyld, David and Janda, Monika (2019). Factors in randomized controlled trials reported to impact the implementation of patient-reported outcome measures into routine care: protocol for a systematic review. JMIR Research Protocols, 8 (11) e14579, e14579. doi: 10.2196/14579

How do cancer care services in Australia take care of their patients when they require emergency care? We need more evidence

Button, Elise, Northfield, Sarah, Smith, Michael, Wyld, David, Nasato, Gillian and Yates, Patsy (2019). How do cancer care services in Australia take care of their patients when they require emergency care? We need more evidence. Australian Health Review, 44 (3), 497-498. doi: 10.1071/AH19118

What is needed by staff to implement PROMs into routine oncology care? A qualitative study with the multi-disciplinary team

Roberts, Natasha A, Alexander, Kim, Wyld, David and Janda, Monika (2019). What is needed by staff to implement PROMs into routine oncology care? A qualitative study with the multi-disciplinary team. European Journal of Cancer Care, 28 (6) e13167, e13167. doi: 10.1111/ecc.13167

A single-blind, randomised controlled trial of StrataXRT® – a silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancer

Chan, Raymond J., Blades, Rae, Jones, Lee, Downer, Tai-Rae, Peet, Samuel C., Button, E., Wyld, D., McPhail, Steven, Doolan, Melissa and Yates, P. (2019). A single-blind, randomised controlled trial of StrataXRT® – a silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancer. Radiotherapy and Oncology, 139, 72-78. doi: 10.1016/j.radonc.2019.07.014

Consensus-derived quality performance indicators for neuroendocrine tumour care

Woodhouse, Braden, Pattison, Sharon, Segelov, Eva, Singh, Simron, Parker, Kate, Kong, Grace, Macdonald, William, Wyld, David, Meyer-Rochow, Goswin, Pavlakis, Nick, Conroy, Siobhan, Gordon, Vallerie, Koea, Jonathan, Kramer, Nicole, Michael, Michael, Wakelin, Kate, Asif, Tehmina, Lo, Dorothy, Price, Timothy, Lawrence, Ben and Commonwealth Neuroendocrine Tumour Collaboration (CommNETs) (2019). Consensus-derived quality performance indicators for neuroendocrine tumour care. Journal of Clinical Medicine, 8 (9) 1455, 1455. doi: 10.3390/jcm8091455

Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test

McCrary, J. Matt, Goldstein, David, Wyld, David, Henderson, Robert, Lewis, Craig R. and Park, Susanna B. (2019). Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test. Journal of Cancer Survivorship, 13 (4), 495-502. doi: 10.1007/s11764-019-00769-7

Reciprocity, autonomy, and vulnerability in men’s experiences of informal cancer care

Kenny, Katherine, Broom, Alex, Kirby, Emma, Oliffe, John L., Wyld, David and Lwin, Zarnie (2019). Reciprocity, autonomy, and vulnerability in men’s experiences of informal cancer care. Qualitative Health Research, 30 (4), 104973231985596-503. doi: 10.1177/1049732319855962

Taking care of our own: a narrative review of cancer care services-led models of care providing emergent care to patients with cancer

Northfield, Sarah, Button, Elise, Wyld, David, Gavin, Nicole Claire, Nasato, Gillian and Yates, Patsy (2019). Taking care of our own: a narrative review of cancer care services-led models of care providing emergent care to patients with cancer. European Journal of Oncology Nursing, 40, 85-97. doi: 10.1016/j.ejon.2019.02.005

Responses to a cancer diagnosis: a qualitative patient-centred interview study

Kirby, Emma R., Kenny, Katherine E., Broom, Alexander F., Oliffe, John L., Lewis, Sophie, Wyld, David K., Yates, Patsy M., Parker, Rhiannon B. and Lwin, Zarnie (2019). Responses to a cancer diagnosis: a qualitative patient-centred interview study. Supportive Care in Cancer, 28 (1), 229-238. doi: 10.1007/s00520-019-04796-z

Corrigendum: Mapping unmet supportive care needs, quality-of-life perceptions and current symptoms in cancer survivors across the Asia-Pacific region: Results from the International STEP Study (Annals of Oncology (2017) 28 (2552-2558) DOI: 10.1093/annonc/mdx350)

Molassiotis, A., Yates, P., Li, Q., So, W. K. W., Pongthavornkamol, K., Pittayapan, P., Komatsu, H., Thandar, M., Yi, M., Titus Chacko, S., Lopez, V., Butcon, J., Wyld, D. and Chan, R. J. (2019). Corrigendum: Mapping unmet supportive care needs, quality-of-life perceptions and current symptoms in cancer survivors across the Asia-Pacific region: Results from the International STEP Study (Annals of Oncology (2017) 28 (2552-2558) DOI: 10.1093/annonc/mdx350). Annals of Oncology, 30 (3), 493-493. doi: 10.1093/annonc/mdy094

Individualising difference, negotiating culture: intersections of culture and care

Broom, Alex, Kirby, Emma, Kokanović, Renata, Woodland, Lisa, Wyld, David, de Souza, Paul, Koh, Eng-Siew and Lwin, Zarnie (2019). Individualising difference, negotiating culture: intersections of culture and care. Health, 24 (5), 136345931982919-571. doi: 10.1177/1363459319829192

The iPROMOS protocol: a stepped-wedge study to implement routine patient-reported outcomes in a medical oncology outpatient setting

Roberts, Natasha Anne, Mudge, Alison, Alexander, Kim, Wyld, David and Janda, Monika (2019). The iPROMOS protocol: a stepped-wedge study to implement routine patient-reported outcomes in a medical oncology outpatient setting. BMJ Open, 9 (2) e027046, e027046. doi: 10.1136/bmjopen-2018-027046

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Kondrashova, Olga, Topp, Monique, Nesic, Ksenija, Lieschke, Elizabeth, Ho, Gwo-Yaw, Harrell, Maria I., Zapparoli, Giada V., Hadley, Alison, Holian, Robert, Boehm, Emma, Heong, Valerie, Sanij, Elaine, Pearson, Richard B., Krais, John J., Johnson, Neil, McNally, Orla, Ananda, Sumitra, Alsop, Kathryn, Hutt, Karla J., Kaufmann, Scott H., Lin, Kevin K., Harding, Thomas C., Traficante, Nadia, Chenevix-Trench, G., Green, A., Webb, P., Gertig, D., Fereday, S., Moore, S. ... Australian Ovarian Cancer Study (AOCS) (2018). Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma. Nature Communications, 9 (1) 3970. doi: 10.1038/s41467-018-05564-z

Follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors

Singh, Simron, Moody, Lesley, Chan, David L., Metz, David C., Strosberg, Jonathan, Asmis, Timothy, Bailey, Dale L., Bergsland, Emily, Brendtro, Kari, Carroll, Richard, Cleary, Sean, Kim, Michelle, Kong, Grace, Law, Calvin, Lawrence, Ben, McEwan, Alexander, McGregor, Caitlin, Michael, Michael, Pasieka, Janice, Pavlakis, Nick, Pommier, Rodney, Soulen, Michael, Wyld, David and Segelov, Eva (2018). Follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors. JAMA Oncology, 4 (11), 1597-1604. doi: 10.1001/jamaoncol.2018.2428

Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival

Dumbrava, Monica I., Burmeister, Elizabeth A., Wyld, David, Goldstein, David, O'Connell, Dianne L., Beesley, Vanessa L., Gooden, Helen M., Janda, Monika, Jordan, Susan J., Merrett, Neil D., Payne, Madeleine E., Waterhouse, Mary A. and Neale, Rachel E. (2018). Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival. Asia Pacific Journal of Clinical Oncology, 14 (4), 326-336. doi: 10.1111/ajco.12862

Maintaining dose intensity of adjuvant chemotherapy in older patients with breast cancer

Ladwa, Rahul, Kalas, Timothy, Pathmanathan, Shivanshan, Woodward, Natasha, Wyld, David and Sanmugarajah, Jasotha (2018). Maintaining dose intensity of adjuvant chemotherapy in older patients with breast cancer. Clinical Breast Cancer, 18 (5), e1181-e1187. doi: 10.1016/j.clbc.2018.04.016

Perceptions of care and patient-reported outcomes in people living with neuroendocrine tumours

Beesley, Vanessa L., Burge, Matthew, Dumbrava, Monica, Callum, Jack, Neale, Rachel E. and Wyld, David K. (2018). Perceptions of care and patient-reported outcomes in people living with neuroendocrine tumours. Supportive Care in Cancer, 26 (9), 3153-3161. doi: 10.1007/s00520-018-4166-5

Correction: Oncology practitioners' perspectives and practice patterns of post-treatment cancer survivorship care in the Asia-Pacific region: Results from the STEP study [BMC Cancer., 17, (2017) (715)] DOI: 10.1186/s12885-017-3733-3

Chan, Raymond Javan, Yates, Patsy, Li, Qiuping, Komatsu, Hiroko, Lopez, Violeta, Thandar, Myat, Chacko, Selva Titus, So, Winnie Kwok Wei, Pongthavornkamol, Kanaungnit, Yi, Myungsun, Pittayapan, Pongpak, Butcon, Jesson, Wyld, David and Molassiotis, Alex (2018). Correction: Oncology practitioners' perspectives and practice patterns of post-treatment cancer survivorship care in the Asia-Pacific region: Results from the STEP study [BMC Cancer., 17, (2017) (715)] DOI: 10.1186/s12885-017-3733-3. BMC Cancer, 18 (1) 240, 1-1. doi: 10.1186/s12885-018-4105-3

MyD88 and TLR4 expression in epithelial ovarian cancer

Block, Matthew S., Vierkant, Robert A., Rambau, Peter F., Winham, Stacey J., Wagner, Philipp, Traficante, Nadia, Tołoczko, Aleksandra, Tiezzi, Daniel G., Taran, Florin Andrei, Sinn, Peter, Sieh, Weiva, Sharma, Raghwa, Rothstein, Joseph H., Ramón y Cajal, Teresa, Paz-Ares, Luis, Oszurek, Oleg, Orsulic, Sandra, Ness, Roberta B., Nelson, Gregg, Modugno, Francesmary, Menkiszak, Janusz, McGuire, Valerie, McCauley, Bryan M., Mack, Marie, Lubiński, Jan, Longacre, Teri A., Li, Zheng, Lester, Jenny, Kennedy, Catherine J. ... Goode, Ellen L. (2018). MyD88 and TLR4 expression in epithelial ovarian cancer. Mayo Clinic Proceedings, 93 (3), 307-320. doi: 10.1016/j.mayocp.2017.10.023

Tumor cystic necrosis following peptide receptor radionuclide therapy in neuroendocrine tumors

Ladwa, Rahul, Wen Hong, Hooi, Wyld, David, Pattison, David A. and Burge, Matthew (2018). Tumor cystic necrosis following peptide receptor radionuclide therapy in neuroendocrine tumors. Clinical Nuclear Medicine, 43 (3), 186-187. doi: 10.1097/RLU.0000000000001970

"...My biggest worry now is how my husband is going to cope': women's relational experiences of cancer "care' during illness

Gibson, Alexandra F., Broom, Alex, Kirby, Emma, Wyld, David K. and Lwin, Zarnie (2018). "...My biggest worry now is how my husband is going to cope': women's relational experiences of cancer "care' during illness. Journal of Gender Studies, 27 (8), 901-913. doi: 10.1080/09589236.2017.1340154

BRAF mutations in low-grade serous ovarian cancer and response to BRAF inhibition

Moujaber, Tania, Etemadmoghadam, Dariush, Kennedy, Catherine J., Chiew, Yoke-Eng, Balleine, Rosemary L., Saunders, Catherine, Wain, Gerard V., Gao, Bo, Hogg, Russell, Srirangan, Sivatharsny, Kan, Casina, Fereday, Sian, Traficante, Nadia, Patch, Ann-Marie, Pearson, John V., Waddell, Nicola, Grimmond, Sean M., Dobrovic, Alexander, Bowtell, David D.L., Harnett, Paul R., deFazio, Anna, Bowtell, D., Chenevix-Trench, G., Green, A., Webb, P., DeFazio, A., Gertig, D., Traficante, N., Fereday, S. ... Zeps, N. (2018). BRAF mutations in low-grade serous ovarian cancer and response to BRAF inhibition. JCO Precision Oncology, 2 (2), 1-14. doi: 10.1200/PO.17.00221

Biliary stenting in patients with pancreatic cancer: results from a population-based cohort study

Payne, Madeleine, Burmeister, Elizabeth A., Waterhouse, Mary, Jordan, Susan J., O'Connell, Dianne L., Merrett, Neil D., Goldstein, David, Wyld, David, Beesley, Vanessa L., Gooden, Helen, Janda, Monika and Neale, Rachel E. (2018). Biliary stenting in patients with pancreatic cancer: results from a population-based cohort study. Pancreas, 47 (1), 80-86. doi: 10.1097/MPA.0000000000000960

Terminal anticipation: Entanglements of affect and temporality in living with advanced cancer

Kenny, Katherine, Broom, Alex, Kirby, Emma, Wyld, David and Lwin, Zarnie (2017). Terminal anticipation: Entanglements of affect and temporality in living with advanced cancer. Subjectivity, 10 (4), 374-392. doi: 10.1057/s41286-017-0034-x

Oncology practitioners' perspectives and practice patterns of post-treatment cancer survivorship care in the Asia-Pacific region: Results from the STEP study

Chan, Raymond Javan, Yates, Patsy, Li, Qiuping, Komatsu, Hiroko, Lopez, Violeta, Thandar, Myat, Chacko, Selva Titus, So, Winnie Kwok Wei, Pongthavornkamol, Kanaungnit, Yi, Myungsun, Pittayapan, Pongpak, Butcon, Jessica, Wyld, David and Molassiotis, Alex (2017). Oncology practitioners' perspectives and practice patterns of post-treatment cancer survivorship care in the Asia-Pacific region: Results from the STEP study. BMC Cancer, 17 (1) 715, 1-10. doi: 10.1186/s12885-017-3733-3

Cancer on the margins: experiences of living with neuroendocrine tumours

Plage, Stefanie, Gibson, Alexandra, Burge, Matthew and Wyld, David (2017). Cancer on the margins: experiences of living with neuroendocrine tumours. Health Sociology Review, 27 (2), 1-15. doi: 10.1080/14461242.2017.1387068

Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): A pilot randomised controlled trial

Chan, Raymond J., Northfield, Sarah, Larsen, Emily, Mihala, Gabor, Ullman, Amanda, Hancock, Peter, Marsh, Nicole, Gavin, Nicole, Wyld, David, Allworth, Anthony, Russell, Emily, Abu Choudhury, Md, Flynn, Julie and Rickard, Claire M. (2017). Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): A pilot randomised controlled trial. Trials, 18 (1) 458, 458. doi: 10.1186/s13063-017-2207-x

Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice

Ahern, Elizabeth, Harjunpaa, Heidi, Barkauskas, Deborah, Allen, Stacey, Takeda, Kazuyoshi, Yagita, Hideo, Wyld, David, Dougall, William C., Teng, Michele W. L. and Smyth, Mark J. (2017). Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice. Clinical Cancer Research, 23 (19), 5789-5801. doi: 10.1158/1078-0432.CCR-17-0606

Association between pancreatic cancer patients' perception of their care coordination and patient-reported and survival outcomes

Beesley, Vanessa L., Janda, Monika, Burmeister, Elizabeth A., Goldstein, David, Gooden, Helen, Merrett, Neil D., O'Connell, Dianne L., Wyld, David K., Chan, Raymond J., Young, Jane M. and Neale, Rachel E. (2017). Association between pancreatic cancer patients' perception of their care coordination and patient-reported and survival outcomes. Palliative and Supportive Care, 16 (05), 534-543. doi: 10.1017/S1478951517000608

Erratum: Respiratory bronchiolitis-associated interstitial lung disease secondary to electronic nicotine delivery system use confirmed with open lung biopsy

Wyld, David (2017). Erratum: Respiratory bronchiolitis-associated interstitial lung disease secondary to electronic nicotine delivery system use confirmed with open lung biopsy. Respirology Case Reports, 5 (4) e00242. doi: 10.1002/rcr2.242

An analysis of incidental and symptomatic pulmonary embolism (PE) in medical oncology patients

Thaker, D. A., Douglas, E., Blazak, J., Xu, W., Hughes, B., Burge, M., Steinke, K. and Wyld, D. (2017). An analysis of incidental and symptomatic pulmonary embolism (PE) in medical oncology patients. Asia-Pacific Journal of Clinical Oncology, 13 (3), 243-248. doi: 10.1111/ajco.12650

The social reception of women with cancer

Gibson, Alexandra F., Broom, Alex, Kirby, Emma, Wyld, David K. and Lwin, Zarnie (2017). The social reception of women with cancer. Qualitative Health Research, 27 (7), 983-993. doi: 10.1177/1049732316637591

Respiratory bronchiolitis-associated interstitial lung disease secondary to electronic nicotine delivery system use confirmed with open lung biopsy

Flower, Mark, Nandakumar, Lakshmy, Singh, Mahendra, Wyld, David, Windsor, Morgan and Fielding, David (2017). Respiratory bronchiolitis-associated interstitial lung disease secondary to electronic nicotine delivery system use confirmed with open lung biopsy. Respirology Case Reports, 5 (3) e00230, e00230. doi: 10.1002/rcr2.230

Anxiety, depression and quality of life in people with pancreatic cancer and their carers

Janda, Monika, Neale, Rachel E., Klein, Kerenaftali, O'Connell, Dianne L., Gooden, Helen, Goldstein, David, Merrett, Neil D., Wyld, David K., Rowlands, Ingrid J. and Beesley, Vanessa L. (2017). Anxiety, depression and quality of life in people with pancreatic cancer and their carers. Pancreatology, 17 (2), 321-327. doi: 10.1016/j.pan.2017.01.008

A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancy

Kevat, D, Chen, M, Wyld, D, Fagermo, N and Lust, K (2017). A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancy. Obstetric medicine, 10 (3), 142-149. doi: 10.1177/1753495X16687700

Mapping unmet supportive care needs, quality-of-life perceptions and current symptoms in cancer survivors across the Asia-Pacific region: results from the International STEP Study

Molassiotis, A., Yates, P., Li, Q., So, W. K. W., Pongthavornkamol, K., Pittayapan, P., Komatsu, H., Thandar, M., Li, M. -S., Chacko, S. Titus, Lopez, V., Butcon, J., Wyld, D. and Chan, R. J. (2017). Mapping unmet supportive care needs, quality-of-life perceptions and current symptoms in cancer survivors across the Asia-Pacific region: results from the International STEP Study. Annals of Oncology, 28 (10), 2552-2558. doi: 10.1093/annonc/mdx350

Factors associated with quality of care for patients with pancreatic cancer in Australia

Burmeister, Elizabeth A., O'Connell, Dianne L., Jordan, Susan J., Goldstein, David, Merrett, Neil, Wyld, David K., Beesley, Vanessa L., Gooden, Helen M., Janda, Monika and Neale, Rachel E. (2016). Factors associated with quality of care for patients with pancreatic cancer in Australia. Medical Journal of Australia, 205 (10), 459-465. doi: 10.5694/mja16.00567

Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: an Australian population-based study

Burmeister, E. A., Waterhouse, M., Jordan, S. J., O'Connell, D. L., Merrett, N. D., Goldstein, D., Wyld, D., Beesley, V., Gooden, H., Janda, M. and Neale, R. E. (2016). Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: an Australian population-based study. Pancreatology, 16 (5), 873-881. doi: 10.1016/j.pan.2016.06.010

Determinants of outcomes following resection for pancreatic cancer—a population-based study

Waterhouse, Mary A., Burmeister, Elizabeth A., O'Connell, Dianne L., Ballard, Emma L., Jordan, Susan J., Merrett, Neil D., Goldstein, David, Wyld, David, Janda, Monika, Beesley, Vanessa L., Payne, Madeleine E., Gooden, Helen M. and Neale, Rachel E. (2016). Determinants of outcomes following resection for pancreatic cancer—a population-based study. Journal of Gastrointestinal Surgery, 20 (8), 1471-1481. doi: 10.1007/s11605-016-3157-4

Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study

Beesley, Vanessa L., Wockner, Leesa F., O'Rourke, Peter, Janda, Monika, Goldstein, David, Gooden, Helen, Merrett, Neil D., O'Connell, Dianne L., Rowlands, Ingrid J., Wyld, David K. and Neale, Rachel E. (2016). Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study. Supportive Care in Cancer, 24 (8), 3589-3599. doi: 10.1007/s00520-016-3212-4

Using a Delphi process to determine optimal care for patients with pancreatic cancer

Burmeister, Elizabeth A., Jordan, Susan J., O'Connell, Dianne L., Beesley, Vanessa L., Goldstein, David, Gooden, Helen M., Janda, Monika, Merrett, Neil D., Wyld, David and Neale, Rachel E. (2016). Using a Delphi process to determine optimal care for patients with pancreatic cancer. Asia-Pacific Journal of Clinical Oncology, 12 (2), 105-114. doi: 10.1111/ajco.12450

Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study (vol 24, pg 3589, 2016)

Beesley, Vanessa L., Wockner, Leesa F., O'Rourke, Peter, Janda, Monika, Goldstein, David, Gooden, Helen, Merrett, Neil D., O'Connell, Dianne L., Rowlands, Ingrid J., Wyld, David K. and Neale, Rachel E. (2016). Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study (vol 24, pg 3589, 2016). Supportive Care in Cancer, 24 (8), 3601-3602. doi: 10.1007/s00520-016-3251-x

Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer

Schofield, Penelope E., Stockler, M. R., Zannino, D., Tebbutt, N. C., Price, T. J., Simes, R. J., Wong, N., Pavlakis, N., Ransom, D., Moylan, E., Underhill, C., Wyld, D., Burns, I., Ward, R., Wilcken, N. and Jefford, M. (2016). Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer. Supportive Care in Cancer, 24 (1), 401-408. doi: 10.1007/s00520-015-2792-8

RAD51B in familial breast cancer

Pelttari, Liisa M., Khan, Sofia, Vuorela, Mikko, Kiiski, Johanna I., Vilske, Sara, Nevanlinna, Viivi, Ranta, Salla, Schleutker, Johanna, Winqvist, Robert, Kallioniemi, Anne, Dörk, Thilo, Bogdanova, Natalia V., Figueroa, Jonine, Pharoah, Paul D. P., Schmidt, Marjanka K., Dunning, Alison M., García-Closas, Montserrat, Bolla, Manjeet K., Dennis, Joe, Michailidou, Kyriaki, Wang, Qin, Hopper, John L., Southey, Melissa C., Rosenberg, Efraim H., Fasching, Peter A., Beckmann, Matthias W., Peto, Julian, Dos-Santos-silva, Isabel, Sawyer, Elinor J. ... Zeps, N. (2016). RAD51B in familial breast cancer. PLoS One, 11 (5) e0153788, e0153788. doi: 10.1371/journal.pone.0153788

High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq

Kondrashova,Olga, Love, Clare J., Lunke, Sebastian, Hsu, Arthur L., Waring, Paul M., Taylor, Graham R., Australian Ovarian Cancer Study (AOCS) Group, Chenevix-Trench, G. and Wyld, D. (2015). High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq. PLoS One, 10 (11) e0143006, 1-14. doi: 10.1371/journal.pone.0143006

A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers

Burge, Matthew E., O'Rourke, Nick, Cavallucci, David, Bryant, Richard, Francesconi, Alessandra, Houston, Kathleen, Wyld, David, Eastgate, Melissa, Finch, Robert, Hopkins, George, Thomas, Paul and Macfarlane, David (2015). A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers. HPB, 17 (7), 624-631. doi: 10.1111/hpb.12418

A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services

Beesley, Vanessa L., Janda, Monika, Goldstein, David, Gooden, Helen, Merrett, Neil D., O'Connell, Dianne L., Rowlands, Ingrid J., Wyld, David and Neale, Rachel E. (2015). A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services. Psycho-Oncology, 25 (2), 150-157. doi: 10.1002/pon.3887

Describing patterns of care in pancreatic cancer a population-based study

Burmeister, Elizabeth A., O'Connell, Dianne L., Beesley, Vanessa L., Goldstein, David, Gooden, Helen M., Janda, Monika, Jordan, Susan J., Merrett, Neil D., Payne, Madeleine E., Wyld, David and Neale, Rachel E. (2015). Describing patterns of care in pancreatic cancer a population-based study. Pancreas, 44 (8), 1259-1265. doi: 10.1097/MPA.0000000000000384

Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis

Beesley, Vanessa L., Green, Adele C., Wyld, David K., O'Rourke, Peter, Wockner, Leesa F., Defazio, Anna, Butow, Phyllis N., Price, Melanie A., Horwood, Keith R., Clavarino, Alexandra M. and Webb, Penelope M. (2014). Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis. Obstetrical and Gynecological Survey, 69 (5), 257-259. doi: 10.1097/01.ogx.0000450117.94530.01

Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis

Beesley, Vanessa L., Green, Adele C., Wyld, David K., O'Rourke, Peter, Wockner, Leesa F., deFazio, Anna, Butow, Phyliss N., Price, Melanie A., Horwood, Keith R., Clavarino, Alexandra M., Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study - Quality of Life Study Investigators and Webb, Penelope M. (2014). Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis. Gynecologic Oncology, 132 (1), 130-136. doi: 10.1016/j.ygyno.2013.10.004

The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates

Kiely, Belinda E., Martin, Andrew J., Tattersall, Martin H. N., Nowak, Anna K., Goldstein, David, Wilcken, Nicholas R. C., Wyld, David K., Abdi, Ehtesham A., Glasgow, Amanda, Beale, Philip J., Jefford, Michael, Glare, Paul A. and Stockler, Martin R. (2013). The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates. Journal of Clinical Oncology, 31 (28), 3565-3572. doi: 10.1200/JCO.2012.44.7821

Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer - A population-based study

Jordan, S., Steer, C., DeFazio, A., Quinn, M., Obermair, A., Friedlander, M., Francis, J., O'Brien, S., Goss, G., Wyld, D. and Webb, P. (2013). Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer - A population-based study. Gynecologic Oncology, 129 (2), 310-317. doi: 10.1016/j.ygyno.2013.02.007

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

Neoptolemos, John P., Moore, Malcolm J., Cox, Trevor F., Valle, Juan W., Palmer, Daniel H., McDonald, Alexander C., Carter, Ross, Tebbutt, Niall C., Dervenis, Christos, Smith, David, Glimelius, Bengt, Charnley, Richard M., Lacaine, François, Scarfe, Andrew G., Middleton, Mark R., Anthoney, Alan, Ghaneh, Paula, Halloran, Christopher M., Lerch, Markus M., Oláh, Attila, Rawcliffe, Charlotte L., Verbeke, Caroline S., Campbell, Fiona, Büchler, Markus W., European Study Group for Pancreatic Cancer and Wyld, David (2012). Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA, 308 (2), 147-56. doi: 10.1001/jama.2012.7352

Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

Kirchhoff, Tomas, Gaudet, Mia M., Antoniou, Antonis C., McGuffog, Lesley, Humphreys, Manjeet K., Dunning, Alison M., Bojesen, Stig E., Nordestgaard, Borge G., Flyger, Henrik, Kang, Daehee, Yoo, Keun-Young, Noh, Dong-Young, Ahn, Sei-Hyun, Dork, Thilo, Schuermann, Peter, Karstens, Johann H., Hillemanns, Peter, Couch, Fergus J., Olson, Janet, Vachon, Celine, Wang, Xianshu, Cox, Angela, Brock, Ian, Elliott, Graeme, Reed, Malcolm W. R., Burwinkel, Barbara, Meindl, Alfons, Brauch, Hiltrud, Hamann, Ute ... Wyld, David (2012). Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. Plos One, 7 (6) ARTN e35706, e35706-1-e35706-10. doi: 10.1371/journal.pone.0035706

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

Chirgwin, Jacquie, Sun, Zhuoxin, Smith, Ian, Price, Karen N., Thuerlimann, Beat, Ejlertsen, Bent, Bonnefoi, Herve, Regan, Meredith M., Goldhirsch, Aron, Coates, Alan S., International Breast Cancer Study Group (IBCSG) and Wyld, David (2012). The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast Cancer Research and Treatment, 131 (1), 295-306. doi: 10.1007/s10549-011-1741-6

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

Pavel, Marianne E., Hainsworth, John D., Baudin, Eric, Peeters, Marc, Hörsch, Dieter, Winkler, Robert E., Klimovsky, Judith, Lebwohl, David, Jehl, Valentine, Wolin, Edward M., Öberg, Kjell, Van Cutsem, Eric, Yao, James C., RADIANT-2 Study Group and Wyld, D. (2011). Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study. The Lancet, 378 (9808), 2005-2012. doi: 10.1016/S0140-6736(11)61742-X

Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: A pilot study

Newton, Melissa J ., Hayes, Sandi C., Janda, Monika, Webb, Penelope M., Obermair, Andreas, Eakin, Elizabeth G., Wyld, David, Gordon, Louisa G. and Beesley, Vanessa L. (2011). Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: A pilot study. BMC Cancer, 11 (1) 389, 389-1-389-9. doi: 10.1186/1471-2407-11-389

Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

Regan, Meredith M, Price, Karen N, Giobbie-Hurder, Anita, Thürlimann, Beat, Gelber, Richard D, International Breast Cancer Study Group and BIG 1-98 Collaborative Group, Colosimo, M., Cheuk, R., Kenny, L., McCarthy, N. and Wyld, D. (2011). Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer. Breast cancer research : BCR, 13 (3), 209. doi: 10.1186/bcr2837

Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma

Obermair, Andreas, Mileshkin, Linda, Bolz, Katharina, Kondalsamy-Chennakesavan, Srinivas, Cheuk, Robyn, Vasey, Paul, Wyld, David, Goh, Jeffrey, Nicklin, James L., Perrin, Lewis C., Sykes, Peter and Janda, Monika (2011). Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma. Gynecologic Oncology, 120 (2), 179-184. doi: 10.1016/j.ygyno.2010.10.039

Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent

Lickliter, J. D., Francesconi, A. B., Smith, G., Burge, M., Coulthard, A., Rose, S., Griffin, M., Milne, R., McCarron, J., Yeadon, T., Wilks, A., Cubitt, A., Wyld, D. K. and Vasey, P. A. (2010). Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent. British Journal of Cancer, 103 (5), 597-606. doi: 10.1038/sj.bjc.6605841

Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients

Beesley, Vanessa L., Clavarino, Alexandra M., Webb, Penelope M., Wyld, David K., Francesconi, Alessandra B., Horwood, Keith R., Doecke, James D., Loos, Colleen A. and Green, Adele C. (2010). Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients. Supportive Care in Cancer, 18 (8), 943-949. doi: 10.1007/s00520-009-0734-z

Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study

Tebbutt, Niall C., Wilson, Kate, Gebski, Val J., Cummins, Michelle M., Zannino, Diana, Van Hazel, Guy A., Robinson, Bridget, Broad, Adam, Ganju, Vinod, Ackland, Stephen P., Forgeson, Garry, Cunningham, David, Saunders, Mark P., Stockler, Martin R., Chua, Yujo, Zalcberg, John R., Simes, R. John, Price, Timothy J., Price, Tim, Simes, John, Coates, Alan, O'Connell, Diane, Brown, Chris, Hague, Wendy, France, Alyson, Hicks, Sian, James, Rebecca, Masson, Ruby, O'Connell, Rachel ... Gebbie, Chantal (2010). Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study. Journal of Clinical Oncology, 28 (19), 3191-3198. doi: 10.1200/JCO.2009.27.7723

Medical costs and outcomes for Australian women with ovarian cancer: A patient-level analysis over 2.5 years

Gordon, Louisa G., Scuffham, Paul A., Beesley, Vanessa L., Green, Adele C., DeFazio, Anna, Wyld, David K., Clavarino, Alexandra M., Australian Ovarian Cancer Study Group and Webb, Penelope M. (2010). Medical costs and outcomes for Australian women with ovarian cancer: A patient-level analysis over 2.5 years. International Journal of Gynecological Cancer, 20 (5), 757-765. doi: 10.1111/IGC.0b013e3181dbd13f

Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme

Francesconi, Alessandra B., Dupre, Simon, Matos, Marco, Martin, David, Hughes, Brett G., Wyld, David K. and Lickliter, Jason D. (2010). Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme. Journal of Clinical Neuroscience, 17 (8), 970-974. doi: 10.1016/j.jocn.2009.12.009

Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers

Herbertson, Rebecca A., Tebbutt, Niall C., Lee, Fook-Thean, MacFarlane, David J., Chappell, Bridget, Micallef, Noel, Lee, Sze-Ting, Saunder, Timothy, Hopkins, Wendie, Smyth, Fiona E., Wyld, David K., Bellen, John, Sonnichsen, Daryl S., Brechbiel, Martin W., Murone, Carmel and Scott, Andrew M. (2009). Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers. Clinical Cancer Research, 15 (21), 6709-6715. doi: 10.1158/1078-0432.CCR-09-0536

Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: Overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial

Au, Heather-Jane, Karapetis, Christos S., O'Callaghan, Chris J., Tu, Dongsheng, Moore, Malcolm J., Zalcberg, John R., Kennecke, Hagen, Shapiro, Jeremy D., Koski, Sheryl, Pavlakis, Nick, Charpentier, Danielle, Wyld, David, Jefford, Michael, Knight, Gregory J., Magoski, Nadine M., Brundage, Michael D. and Jonker, Derek J. (2009). Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: Overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial. Journal of Clinical Oncology, 27 (11), 1822-1828. doi: 10.1200/JCO.2008.19.6048

Nesidioblastosis as a cause of focal pancreatic 111In-pentetreotide uptake in a patient with putative VIPoma: another differential diagnosis

Francesconi, Alessandra Bastian, Matos, Marco, Lee, Joseph C., Wyld, David K., Clouston, Andrew D. and Macfarlane, David (2009). Nesidioblastosis as a cause of focal pancreatic 111In-pentetreotide uptake in a patient with putative VIPoma: another differential diagnosis. Annals of Nuclear Medicine, 23 (5), 497-499. doi: 10.1007/s12149-009-0252-6

Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial

Stockler, M. R., O'Connell, R., Nowak, A. K., Goldstein, D., Turner, J., Wilcken, N. R. C., Wyld, D., Abdi, E., Glasgow, A., Beale, P. J., Jefford, M., Dhillon, H., Heritier, S., Carter, C., Hickie, I. B. and Simes, R. J. (2007). Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. The Lancet Oncology, 8 (7), 603-612. doi: 10.1016/S1470-2045(07)70148-1

A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma

Kefford, Richard, Beith, Jane McNeil, Van Hazel, Guy Arthur, Millward, Michael, Trotter, James Marshall, Wyld, David Keith, Kusic, Rada, Shreeniwas, Revati, Morganti, Adele, Ballmer, Andrea, Segal, Eleonor, Nayler, Oliver and Clozel, Martine (2007). A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma. Investigational New Drugs, 25 (3), 247-252. doi: 10.1007/s10637-006-9014-7

Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer

Friedlander, M, Buck, M, Wyld, D, Findlay, M, Fitzharris, B, De Souza, P, Davies, T, Kalimi, G, Allan, S, Perez, D and Harnett, P (2007). Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer. International Journal of Gynecological Cancer, 17 (2), 350-358. doi: 10.1111/j.1525-1438.2007.00795.x

Metastatic paraganglioma with extensive bone marrow involvement

Morris, Kirk L., Macfarlane, David, Wyld, David and Kennedy, Glen A. (2006). Metastatic paraganglioma with extensive bone marrow involvement. Asia-Pacific Journal of Clinical Oncology, 2 (4), 193-194. doi: 10.1111/j.1743-7563.2006.00068.x

Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer

Le Chevalier, T., Arriagada, R., Le Pechoux, C., Grunenwald, D., Dunant, A., Pignon, J. P., Tarayre, M., Abratt, R., Arriagada, R., Bergman, B., Gralla, R., Grunenwald, D., Le Chevalier, T., Orlowski, T., Papadakis, E., Pinel, M. I. Sathler, Araujo, C., Della Torre, H., de Solchaga, M. Masetto, Abdi, E., Blum, R., Ball, D., Basser, R., De Boer, R., Bishop, J., Brigham, B., Davis, S., Fox, D., Richardson, G. ... Wedel, H. (2004). Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. New England Journal of Medicine, 350 (4), 351-360. doi: 10.1056/NEJMoa031644

Conquering chemotherapy

Horwood, Keith and Wyld, David (2000). Conquering chemotherapy. Australian Prescriber, 23 (3).

Conquering chemotherapy [3] (multiple letters)

Allison, R., Horwood, K. and Wyld, D. (2000). Conquering chemotherapy [3] (multiple letters). Australian Prescriber, 23 (3).

Cisplatin-based therapy: A neurological and neurophysical review

Troy, L., McFarland, K. A., Littman-Powers, S., Kelly, B. J., Walpole, E. T., Wyld, D. and Thomson, D. (2000). Cisplatin-based therapy: A neurological and neurophysical review. Psychooncology, 9 (1), 29-39. doi: 10.1002/(SICI)1099-1611(200001/02)9:1

Cisplatin-based therapy: A neurological and neuropsychological review

Troy, L., McFarland, K., Littman-Power, S., Kelly, B.J., Walpole, E.T., Wyld, D. and Thomson, D. (2000). Cisplatin-based therapy: A neurological and neuropsychological review. Psycho-oncology, 9 (1), 29-39. doi: 10.1002/(SICI)1099-1611(200001/02)9:1

Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20

Wyld, DK, Selby, P, Perren, TJ, Jonas, SK, Allen-Mersh, TG, Wheeldon, J and Burchill, SA (1998). Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. International Journal of Cancer, 79 (3), 288-293. doi: 10.1002/(SICI)1097-0215(19980619)79:3<288::AID-IJC14>3.3.CO;2-2

Endocrine aspects of the clinical management of breast cancer - Current issues

Wyld, DK, Chester, JD and Perren, TJ (1998). Endocrine aspects of the clinical management of breast cancer - Current issues. Endocrine-Related Cancer, 5 (2), 97-110. doi: 10.1677/erc.0.0050097

An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs)

Zebic, Danka Sinikovic, Tran, Ben, Martin, Andrew James, Pashankar, Farzana D., Mazhar, Danish, Huddart, Robert A., Wheater, Matthew, Walpole, Euan Thomas, Dunwoodie, Elaine, Feldman, Darren R., Birtle, Alison Jane, Wyld, David, Lawrence, Nicola Jane, Stockler, Martin R., Grimison, Peter S. and Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) (2023). An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs). 2023 ASCO Annual Meeting, Chicago, IL United States, 2-6 June 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.16_suppl.tps5102

P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs)

Zebic, Danka Sinikovic, Ben Tran, , Martin, Andrew James, Pashankar, Farzana D., Mazhar, Danish, Huddart, Robert A., Wheater, Matthew, Walpole, Euan Thomas, Dunwoodie, Elaine, Feldman, Darren R., Birtle, Alison Jane, Wyld, David, Lawrence, Nicola Jane, Stockler, Martin R. and Grimison, Peter S. (2023). P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

PRRT for control of hypoglycaemia and disease progression due to metastatic insulinoma

Pattison, D. A., Kong, G., Hofman, M. S., Akhurst, T., Ravi, Kumar A. S., Michael, M., Wyld, D., Burge, M., Chiang, C., Sachithanandan, N., Love, A. and Hicks, R. (2023). PRRT for control of hypoglycaemia and disease progression due to metastatic insulinoma. 20th Annual ENETs Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Electr Network, Mar 22-24, 2023. HOBOKEN: WILEY.

P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate- and poor-risk metastatic germ cell tumours (GCTs)

Zebic, Danka, Stockler, Martin R., Martin, Andrew James, Pashankar, Farzana D., Tran, Ben, Mazhar, Danish, Huddart, Robert A., Wheater, Matthew, Walpole, Euan Thomas, Dunwoodie, Elaine, Feldman, Darren R., Birtle, Alison Jane, Stevanovic, Amanda Gwendolyn, Wyld, David, Hanning, Fritha J., Grimison, Peter S. and Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) (2023). P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate- and poor-risk metastatic germ cell tumours (GCTs). 2023 ASCO Genitourinary Cancers Symposium, San Francisco, CA United States, 16-18 February 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.6_suppl.tps431

P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediateand poor-risk metastatic germ cell tumours (GCTs)

Zebic, Danka, Stockler, Martin R., Martin, Andrew James, Pashankar, Farzana D., Ben Tran, , Mazhar, Danish, Huddart, Robert A., Wheater, Matthew, Walpole, Euan Thomas, Dunwoodie, Elaine, Feldman, Darren R., Birtle, Alison Jane, Stevanovic, Amanda Gwendolyn, Wyld, David, Hanning, Fritha J. and Grimison, Peter S. (2023). P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediateand poor-risk metastatic germ cell tumours (GCTs). Genitourinary Cancers Symposium, Electr Network, Feb 16-18, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs)

Zebic, Danka, Stockler, Martin R., Martin, Andrew, Pashankar, Farzana, Ben Tran, , Mazhar, Danish, Huddart, Robert, Wheater, Matthew, Walpole, Euan, Dunwoodie, Elaine, Feldman, Darren, Birtle, Alison, Stevanovic, Amanda G., Wyld, David, Hanning, Fritha J. and Grimison, Peter S. (2022). P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs). HOBOKEN: WILEY.

Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: <SUP>177</SUP>Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) and capecitabine plus temozolomide (CAPTEM) for pancreas and midgut neuroendocrine tumours (pNETS, mNETS)-Final results

Pavlakis, Nick, Ransom, David Turner, Wyld, David, Sjoquist, Katrin Marie, Wilson, Kate, Gebski, Val, Murray, James, Kiberu, Andrew Ddembe, Burge, Matthew E., Macdonald, William, Roach, Paul, Pattison, David A., Butler, Patrick, Price, Timothy Jay, Michael, Michael, Lawrence, Benjamin James, Bailey, Dale L., Leyden, Simone, Zalcberg, John Raymond and Turner, Harvey (2022). Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) and capecitabine plus temozolomide (CAPTEM) for pancreas and midgut neuroendocrine tumours (pNETS, mNETS)-Final results. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with somatostatin-expressing neuroendocrine tumors: a real-world retrospective review of efficacy and safety from an Australian tertiary cancer Center

Nalder, Mark, Ladwa, Rahul, Raina, Anant, Burge, Matthew E., Love, Amanda, Pattison, David A., Ramsay, Stuart and Wyld, David (2021). 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with somatostatin-expressing neuroendocrine tumors: a real-world retrospective review of efficacy and safety from an Australian tertiary cancer Center. 2021 ASCO Annual Meeting I, Virtual, 4-8 June 2021. Alexandria, VA USA: American Society of Clinical Oncology. doi: 10.1200/jco.2021.39.15_suppl.e16198

P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs)

Subramaniam, Shalini, Toner, Guy C., Stockler, Martin R., Martin, Andrew James, Pashankar, Farzana D., Frazier, A. Lindsay, Mazhar, Danish, Ford, Kate, Walpole, Euan Thomas, Stevanovic, Amanda Gwendolyn, Wyld, David, Troon, Simon, Hanning, Fritha J., Birtle, Alison Jane, Wheater, Matthew James, Huddart, Robert A., White, Jeff D., Spunt, Sheri L. and Grimison, Peter S. (2020). P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs). Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco Ca, Feb 13-15, 2020. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Insights into the practice patterns, challenges and the role of a shared care model in the management of neuroendocrine (NET) patients in the community

Radhika, Y., Chan, D., Thawer, A., Lo, D., Singh, S. and Wyld, D. (2020). Insights into the practice patterns, challenges and the role of a shared care model in the management of neuroendocrine (NET) patients in the community. 17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Electr Network, 11-13 March 2020. Basel, Switzerland: S. Karger.

Ontario oncologists' perspectives on addressing potential barriers in the management of patients with neuroendocrine tumors

Fingrut, Warren, Yelamanchili, Radhika, Thawer, Alia, Chan, David, Wyld, David, Singh, Simron and Lo, Dorothy (2019). Ontario oncologists' perspectives on addressing potential barriers in the management of patients with neuroendocrine tumors. 11th Annual Meeting of the North American Neuroendocrine Tumor Society, Seattle, Washington, October 4-6, 2018. Philadelphia, PA, United States: Lippincott Williams & Wilkins. doi: 10.1097/MPA.0000000000001250

Practice Patterns, Challenges, and the Role of a Shared Care Model in the Management of Neuroendocrine (NET) Patients

Yelamanchili, Radhika, Thawer, Alia, Chan, David, Lo, Dorothy, Singh, Simron, Fingrut, Warren and Wyld, David (2019). Practice Patterns, Challenges, and the Role of a Shared Care Model in the Management of Neuroendocrine (NET) Patients. 11th Annual Meeting of the North American Neuroendocrine Tumor Society, Seattle, Washington, October 4-6, 2018. Philadelphia, PA, United States: Lippincott Williams & Wilkins. doi: 10.1097/MPA.0000000000001250

Royal Brisbane MedicalOncology Clinic Activity Review

Kuchel, Anna, Kermond, Anna, Lonton, Jennifer, Wyld, David and Eastgate, Melissa (2019). Royal Brisbane MedicalOncology Clinic Activity Review. COSA's 46th Annual Scientific Meeting, Urological cancer; Age and gender in cancer practice; Digital health in cancer, Adelaide, SA Australia, 12–14 November 2019. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Implementing a highly accessible model of screening and assessment in geriatric oncology: Our experience

Bryant, Geoffrey, Thaker, Darshit, Wyld, David, Leach, Justine, Wheatley, Hermione and Garth, Vanessa (2018). Implementing a highly accessible model of screening and assessment in geriatric oncology: Our experience. HOBOKEN: WILEY.

Is survival improving for patients diagnosed with small intestinal neuroendocrine tumours in Queensland?

Moore, Julie, Dunn, Nathan, Tran, Nancy and Wyld, David (2018). Is survival improving for patients diagnosed with small intestinal neuroendocrine tumours in Queensland?. HOBOKEN: WILEY.

A randomized controlled study comparing treatment of gastro-entero-pancreatic neuroendocrine tumors (GEPNET) with 177Lu-DOTATATE alone and in combination with capecitabine

Van der Zwan, W., Wyld, D., Brabander, T., Teunissen, J., Kam, B., MacFarlane, D., Krenning, E., Kwekkeboom, D. and de Herder, W. (2018). A randomized controlled study comparing treatment of gastro-entero-pancreatic neuroendocrine tumors (GEPNET) with 177Lu-DOTATATE alone and in combination with capecitabine. 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 7 - 9 March 2018. Basel, Switzerland: S. Karger AG.

Colorectal cancer patient reported outcomes: putting theory into practice

Bryant, Geoffrey, Eastgate, Melissa, Wyld, David, Burge, Matthew, Thaker, Darshit and Busato, Matthew (2018). Colorectal cancer patient reported outcomes: putting theory into practice. COSA's 45th Annual Scientific Meeting, Mesothelioma and Gastro‐Intestinal Cancers: Technology and Genomics, Perth Convention and Exhibition Centre, 13–15 November 2018. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Dietary patterns and attitudes in cancer survivors

Lee, Shu Fen , Wyld, David , Eastgate, Melissa and Brown, Teresa (2018). Dietary patterns and attitudes in cancer survivors. Victorian Cancer Survivorship Conference, Melbourne, Australia, 8-9 February 2018.

How the Rare See Their Care: Perceptions of Care and Patient Reported Outcomes in People Living with Neuroendocrine Tumors

Wyld, D., Burge, M., Dumbrava, M., Callum, J., Neale, R. and Beesley, V. (2018). How the Rare See Their Care: Perceptions of Care and Patient Reported Outcomes in People Living with Neuroendocrine Tumors. 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 7-9 March 2018. Basel, Switzerland: Karger. doi: 10.1159/000487699

How the rare see their care: Perceptions of care and patient reported outcomes in people living with neuroendocrine tumours

Wyld, D., Burge, M., Dumbrava, M., Callum, J., Neale, R. and Beesley, V. (2018). How the rare see their care: Perceptions of care and patient reported outcomes in people living with neuroendocrine tumours. Victorian Cancer Survivorship Conference, Melbourne, Australia, 8 -9 February 2018.

Neuroendocrine Neoplasm Trends Over 32 Years in Queensland, Australia

Wan, Mark H., Moore, Julie and Wyld, David K. (2018). Neuroendocrine Neoplasm Trends Over 32 Years in Queensland, Australia. Princess Margaret Cancer Conference. Accelerating Precision Medicine 2018, Toronto Canada, January 19 2018.

Positron Emission Tomography (PET) predictors of tumor response to Peptide Receptor Radionuclide Therapy (PRRT) in metastatic Neuroendocrine Tumors (NET)

Ladwa, R., Pattison, D., Smith, J., Goodman, S., Burge, M., Rose, S., Dowson, N. and Wyld, D. (2018). Positron Emission Tomography (PET) predictors of tumor response to Peptide Receptor Radionuclide Therapy (PRRT) in metastatic Neuroendocrine Tumors (NET). 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 7-9 March 2018. Basel, Switzerland: S. Karger AG.

Pretherapeutic predictors of tumor absorbed dosimetry in radionuclide therapy for metastatic neuroendocrine tumors

Ladwa, R., Pattison, D., Smith, J., Goodman, S., Burg, M., Rose, S., Dowson, N. and Wyld, D. (2018). Pretherapeutic predictors of tumor absorbed dosimetry in radionuclide therapy for metastatic neuroendocrine tumors. 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 7-9 March 2018. Basel, Switzerland: S. Karger AG.

Tumor absorbed dosimetry and response of radionuclide therapy in metastatic neuroendocrine tumor

Ladwa, R., Pattison, D., Smith, J., Goodman, S., Burge, M., Rose, S., Dowson, N. and Wyld, D. (2018). Tumor absorbed dosimetry and response of radionuclide therapy in metastatic neuroendocrine tumor. 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 7-9 March 2018. Basel, Switzerland: S. Karger AG.

Validation of Abbreviated 177Lu-DOTATATE Renal and Lesional Dosimetry Protocol using Quantitative SPECT

Goodman, Steven , Patford, Shaun , Ladwa, Rahul , Smith, Jye , Wyld, David and Pattison, David A. (2018). Validation of Abbreviated 177Lu-DOTATATE Renal and Lesional Dosimetry Protocol using Quantitative SPECT. 12th Congress of the World Federation of Nuclear Medicine and Biology., Melbourne Australia, 20-24 April 2018.

Characterising Acute Ward Admissions of Advanced Cancer Patients to the Royal Brisbane Hospital

Mittal, Dolly, Eustace, Matthew, Eastgate, Melissa, Burge, Matthew and Wyld, David (2017). Characterising Acute Ward Admissions of Advanced Cancer Patients to the Royal Brisbane Hospital. WILEY.

Neuroendocrine neoplasm trends over 32 Years in Queensland, Australia

Wyld, D. K., Wan, M. H. and Moore, J. (2017). Neuroendocrine neoplasm trends over 32 Years in Queensland, Australia. 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 8-10 March 2017. Basel, Switzerland: Karger. doi: 10.1159/000484263

Outcomes comparing right and left-sided metastatic colorectal cancer: A multi-centre retrospective analysis in Queensland, Australia

Allen, Michael , Conroy, Sophie , Eastgate, Melissa , Wyld, David, Whitehall, Vicki and Burge, Matthew (2017). Outcomes comparing right and left-sided metastatic colorectal cancer: A multi-centre retrospective analysis in Queensland, Australia. Australasian Gastro-Intestinal Trials Group (AGITG) 2017 Annual Scientific Meeting, Cairns Convention Centre, Cairns, Australia, 4-6 October 2017. AGITG.

Patient reported outcomes (PROs) in clinical practice: a scoping review of reviews, systematic review and meta-analysis of the research

Roberts, Natasha, Janda, Monika, Alexander, Kim and Wyld, David (2017). Patient reported outcomes (PROs) in clinical practice: a scoping review of reviews, systematic review and meta-analysis of the research. 2017 World Congress of Psycho-Oncology, 14-18 August, Berlin, Germany. Oxford, United Kingdom: John Wiley & Sons.

Single institution review of the correlation between the clinical and histopathological staging in newly diagnosed rectal cancer patients in 2015

Thanayankeezhil, Padmini, Wyld, David, Burge, Matthew and Eastgate, Melissa (2017). Single institution review of the correlation between the clinical and histopathological staging in newly diagnosed rectal cancer patients in 2015. Australasian Gastro-Intestinal Trials Group (AGITG) 2017 Annual Scientific Meeting, Cairns Convention Centre, Cairns, Australia, 4-6 October 2017. AGITG.

Understanding staff needs when implementing Patient Reported Outcomes (PROs) in the clinical setting: a qualitative study

Roberts, Natasha, Janda, Monika, Alexander, Kim and Wyld, David (2017). Understanding staff needs when implementing Patient Reported Outcomes (PROs) in the clinical setting: a qualitative study. 2017 World Congress of Psycho-Oncology, 14-18 August 2017, Berlin, Germany. HOBOKEN: WILEY.

‘How long is the piece of string?’ – How patients negotiate the uncertainties of a Neuroendocrine tumour diagnosis

Wyld, David , Plage, Stefanie , Burge, Matthew , Broom, Alex , Lwin, Zarnie , McDade, Helen and Cubitt, Annette (2017). ‘How long is the piece of string?’ – How patients negotiate the uncertainties of a Neuroendocrine tumour diagnosis. Cancer Survivorship 2017, Adelaide, SA, Australia, 2-3 February 2017.

A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET)

Ladwa, R., Burge, M. and Wyld, D. (2016). A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET). 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

A prospective 2-year experience of a medical oncology advanced trainee in Queensland

Ladwa, Rahul, Chern, Boris, Sanmugarajah, Jasotha and Wyld, David (2016). A prospective 2-year experience of a medical oncology advanced trainee in Queensland. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing.

A single center experience of cardiac metastasis from neuroendocrine tumors (net)

Ladwa, Rahul, Burge, Matthew and Wyld, David (2016). A single center experience of cardiac metastasis from neuroendocrine tumors (net). COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646

A systematic review and meta-analysis of patient reporting outcomes in clinical practice

Roberts, Natasha, Janda, Monika, Alexander, Kimberley and Wyld, David (2016). A systematic review and meta-analysis of patient reporting outcomes in clinical practice. COSA's 43rd and ANZBCTG's 38th Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, Australia, 15–17 November 2016. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12635_4

Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand)

Chan, B. A., Sim, H-W., Ravikumar, A., Bailey, D., Chan, D., Lawrence, B., McEwan, A., Pavlakis, N., Segelov, E., Singh, S., Roach, P. and Wyld, D. (2016). Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand). Oxford, United Kingdom: Oxford University Press.

Dosimetry to Estimate the Effect of Gelofusine (R) on the Renal Absorbed Dose of Lutetium 177-DOTA-Octreotate

Lucas, C., Goodman, S., Smith, J., Burge, M., Wyld, D. and Kumar, Ravi A. (2016). Dosimetry to Estimate the Effect of Gelofusine (R) on the Renal Absorbed Dose of Lutetium 177-DOTA-Octreotate. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

How Long Is the Piece of String? - How Patients Negotiate the Uncertainties of a NET Diagnosis

Wyld, D., Plage, S., Burge, M., Broom, A., Lwin, Z., McDade, H. and Cubitt, A. (2016). How Long Is the Piece of String? - How Patients Negotiate the Uncertainties of a NET Diagnosis. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

Optimizing adjuvant chemotherapy delivery in older women with breast cancer - a review

Kalas, Timothy S. and Wyld, David (2016). Optimizing adjuvant chemotherapy delivery in older women with breast cancer - a review. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast International Hotel, Gold Coast, Queensland, Australia,, Gold Coast, QLD Australia. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646

Pretherapy Identification of Patients at Risk of Receiving a High Renal Dose Undergoing Peptide Receptor Radionuclide Therapy

Goodman, S., Smith, J., Kumar, Ravi A., Wyld, D. and Burge, M. (2016). Pretherapy Identification of Patients at Risk of Receiving a High Renal Dose Undergoing Peptide Receptor Radionuclide Therapy. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic Pseudoprogression

Ladwa, R., Lyle, M., Wyld, D. and Burge, M. (2016). The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic Pseudoprogression. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations

Gunawan, Ben, Button, Elise, Bates, Tracey, Nasato, Gillian and Wyld, David (2016). Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646

A Phase II Study of Everolimus in patients with FDG-PET positive intermediate grade (Ki67 3-20%) pancreatic neuroendocrine tumor

Michael, M., Pavlakis, N., Wyld, D., Link, E., Liauw, W., Kuru, N. and Hicks, R. (2015). A Phase II Study of Everolimus in patients with FDG-PET positive intermediate grade (Ki67 3-20%) pancreatic neuroendocrine tumor. 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, March 11-13, 2015. Basel, Switzerland: S. Karger AG. doi: 10.1159/000431385

A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancy

Kevat, D., Chen, M., Wyld, D., Fagermo, N. and Lust, K. (2015). A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancy. RCOG World Congress 2015, 12–15 April, Brisbane, Queensland, Australia, Brisbane, Queensland, Australia, 12–15 April 2015. Chichester, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/1471-0528.13370

A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302)

Lawrence, Nicola, Toner, Guy, Martin, Andrew, Stockler, Martin, Yeung, Annie, Wong, Nicole, Thomson, Damien, Gebski, Val, Yip, Sonia, King, Madeleine, Friedlander, Michael, Quinn, David, Tan, Thean Hsiang, Chan, Howard, Hanning, Fritha, Weickhardt, Andrew, Jeffery, Mark, Stevanovic, Amanda, Hovey, Elizabeth, Wyld, David, Davis, Ian and Grimison, Peter (2015). A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302). COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2

Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional study

Jan, H., Wyld, D. and Burge, M. (2015). Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional study. 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, Mar 11-13, 2015. Basel, Switzerland: S. Karger AG. doi: 10.1159/000431385

Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare Cancer

Wyld, David, Gibson, Alexandra, Broom, Alex, Plage, Stefanie, Cubitt, Annette and Lwin, Zarnie (2015). Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare Cancer. COSA’s 42nd Annual Scientific Meeting. Rare Cancers, Hobart, TAS, Australia, 17-19 November 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2

Patient understanding of research in a medical oncology setting

Roberts, Natasha, Ives, Amy, Wyld, David and Cubitt, Annette (2015). Patient understanding of research in a medical oncology setting. COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2

Assessment of long course chemoradiotherapy (Lccrt) in regards to completion of chemotherapy. The experience of a tertiary referral hospital

Christie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Assessment of long course chemoradiotherapy (Lccrt) in regards to completion of chemotherapy. The experience of a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (Lccrt) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospital

Christie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (Lccrt) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Locally advanced and metastatic pancreatic cancer: an assessment of the provision of chemotherapy at a tertiary referral hospital

Christie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Locally advanced and metastatic pancreatic cancer: an assessment of the provision of chemotherapy at a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Novel succinate dehydrogenase subunit B intronic mutation in an Australian kindred with variable clinical and imaging phenotype necessitating different treatment modalities including 131-I MIBG and 177-Lutetium DOTATATE

Lee, K., Conway, L., Burge, M., Wyld, D. and Macfarlane, D. (2014). Novel succinate dehydrogenase subunit B intronic mutation in an Australian kindred with variable clinical and imaging phenotype necessitating different treatment modalities including 131-I MIBG and 177-Lutetium DOTATATE. 11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 5 - 7 March 2014. Basel, Switzerland: S. Karger AG.

Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (Lccrt). An assessment at a tertiary referral hospital

Christie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (Lccrt). An assessment at a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Rural Oncology Care Via Teleoncology and Outreach Clinics: Patient and Staff Perspectives and Comparisons

Wyeth, Holly, Chan, Bryan, Burge, Matthew, Wyld, David and Eastgate, Melissa (2014). Rural Oncology Care Via Teleoncology and Outreach Clinics: Patient and Staff Perspectives and Comparisons. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, VIC Australia, 2-4 December 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyrapone

Chan, B. A., Wyld, D., Burge, M., Cuneo, R., Macfarlane, D. and Lee, K. (2014). Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyrapone. 11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, 5 - 7 March 2014. Basel, Switzerland: S. Karger AG.

Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (Lccrt) for metropolitan versus rural patients referred to a Queensland tertiary referral hospital

Christie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (Lccrt) for metropolitan versus rural patients referred to a Queensland tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Pancreatic cancer patient's moderate or high unmet supportive care needs over time and risk factors of future unmet needs

Beesley, Vanessa L., Janda, Monika, Wockner, Leesa F., O'Rourke, Peter, Gooden, Helen, Goldstein, David, Merrett, Neil D., Wyld, David K. and Neale, Rachel E. (2013). Pancreatic cancer patient's moderate or high unmet supportive care needs over time and risk factors of future unmet needs. COSA's 40th Annual Scientific Meeting. Cancer Care Coming of Age, Adelaide Convention Centre, Adelaide, SA Australia, 12-14 November 2013. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Pulmonary Embolism in Medical Oncology Patients: Symptomatic Versus Incidental

Thaker, D. A., Blazak, J., Wyld, D., Steinke, K., Hughes, B. and Burge, M. (2012). Pulmonary Embolism in Medical Oncology Patients: Symptomatic Versus Incidental. HOBOKEN: WILEY-BLACKWELL.

Usefulness of medical oncologists' estimates of survival time in people with advanced cancer.

Kiely, Belinda E., Martin, Andrew J., Tattersall, Martin H. N., Nowak, Anna K., Goldstein, David, Wilcken, Nicholas, Wyld, David, Beale, Philip James, Jefford, Michael, Glasgow, Amanda L., Abdi, Ehtesham A., Glare, Paul A. and Stockler, Martin R. (2012). Usefulness of medical oncologists' estimates of survival time in people with advanced cancer.. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. AMER SOC CLINICAL ONCOLOGY.

Analysis of plasma biomarkers potentially associated with antiangiogenic resistance in NCIC CTG/AGITG CO.20: A phase III randomized trial of cetuximab (CET) plus either brivanib alaninate (BRIV) or placebo in patients (pts) with chemotherapy refractory, k

Shapiro, Jeremy David, Siu, Lillian L., O'Callaghan. Christopher J., Zalcberg, John Raymond, Moore, Malcolm J., Price, Timothy Jay, Doyle, Catherine, Simes, John, Findlay, Brian Peter, Cronk, Michelle F., Shaikh, Asif, Joubert, Warren Lance, Samson, Benoit, Bonaventura, Antonino, Underhill, Craig, Wyld, David, Walters, Ian B., Phillips, Penny, Tu, Dongsheng and Jonker, Derek J. (2012). Analysis of plasma biomarkers potentially associated with antiangiogenic resistance in NCIC CTG/AGITG CO.20: A phase III randomized trial of cetuximab (CET) plus either brivanib alaninate (BRIV) or placebo in patients (pts) with chemotherapy refractory, k. 2012 ASCO Annual Meeting, Chicago Il, United States, 01-05 June 2012. Alexandria, VA United States: American Society of Clinical Oncology.

Safety of bevacizumab used in routine practice in patients with metastatic colorectal cancer

Dzienis, M., Malczewski, A., Goh, J., Hughes, B., Eastgate, M., Wyld, D. and Burge, M. (2012). Safety of bevacizumab used in routine practice in patients with metastatic colorectal cancer. Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, Program and Abstracts: Targeting Cancer from Diagnosis to Cure & 5th Annual COGNO Annual Scientific Meeting, Brisbane, QLD Australia, 8-10 August 2012. Wiley-Blackwell Publishing.

Treatment of metastatic neuroendocrine tumours with (Lu)-L-177-octreotate: experience at Royal Brisbane and Women's Hospital

Sharma, A., Burge, M., MacFarlane, D., McDade, H., Kemp, S. and Wyld, D. (2012). Treatment of metastatic neuroendocrine tumours with (Lu)-L-177-octreotate: experience at Royal Brisbane and Women's Hospital. Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, Program and Abstracts: Targeting Cancer from Diagnosis to Cure & 5th Annual COGNO Annual Scientific Meeting , Brisbane, QLD, Australia, 8 – 10 August 2012. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Does the addition of FDG-PET to the standard pre-operative work up of pancreatic cancer change management - a prospective study

Burge, M., Houston, K. E., Francesconi, A., O'Rourke, N., Lee, J., Macfarlane, D., Wyld, D., Hopkins, G., Finch, R. and Nathanson, L. (2011). Does the addition of FDG-PET to the standard pre-operative work up of pancreatic cancer change management - a prospective study. European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, Sweden, 23 - 27 September 2011. Elsevier: Oxford, United Kingdom.

Phase I evaluation of CYT997, a novel cytotoxic and vascular-disrupting agent, in patients with advanced cancer

Lickliter, J., Francesconi, A., Smith, G., Burge, M., Coulthard, A., Rose, S., Griffin, M., Wilks, A., Wyld, D. and Vasey, P. (2008). Phase I evaluation of CYT997, a novel cytotoxic and vascular-disrupting agent, in patients with advanced cancer. 2008 ASCO Annual Meeting, Chicago, IL, U.S.A., 30 May - 3 June, 2008. Alexandria, VA. U.S.A.: American Society of Clinical Oncology.

Analysis of expression of Eph/Ephrin tyrosine kinases in advanced ovarian cancer.

Sabesan, SS, Wyld, D, Herath, N and Boyd, A (2005). Analysis of expression of Eph/Ephrin tyrosine kinases in advanced ovarian cancer.. 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Orlando Fl, May 13-17, 2005. AMER SOC CLINICAL ONCOLOGY.

A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage TV metastatic melanoma

Kefford, R, Beith, J, Van Hazel, GA, Millward, M, Trotter, J, Wyld, D, Kusic, R, Coward, J, Shreeniwas, R and Morganti, A (2005). A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage TV metastatic melanoma. ESMO Scientific and Educational Conference (ESEC), Budapest Hungary, Jun 02-05, 2005. OXFORD: OXFORD UNIV PRESS.